Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.

Burrai GP, Mohammed SI, Miller MA, Marras V, Pirino S, Addis MF, Uzzau S, Antuofermo E.

BMC Cancer. 2010 Apr 22;10:156. doi: 10.1186/1471-2407-10-156.

2.

Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.

Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed SI.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2247-56. Epub 2007 Nov 2.

3.

Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease.

Mouser P, Miller MA, Antuofermo E, Badve SS, Mohammed SI.

Vet Pathol. 2010 Mar;47(2):275-84. doi: 10.1177/0300985809358603. Epub 2010 Jan 22.

PMID:
20106771
5.

17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.

Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Satomi S, Sasano H.

Anticancer Res. 2000 Mar-Apr;20(2B):1101-8.

PMID:
10810403
7.
8.

Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.

Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Sasano H.

Jpn J Cancer Res. 2000 Nov;91(11):1169-76.

PMID:
11092983
10.

Alterations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications.

Liu C, Zhang H, Shuang C, Lu Y, Jin F, Xu H, Lu P.

Med Oncol. 2010 Sep;27(3):747-52. doi: 10.1007/s12032-009-9279-8. Epub 2009 Aug 6.

PMID:
19657752
11.

Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Brower ST, Ahmed S, Tartter PI, Bleiweiss I, Amberson JB.

Ann Surg Oncol. 1995 Sep;2(5):440-4.

PMID:
7496840
12.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
13.

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD.

J Natl Cancer Inst. 2010 May 5;102(9):627-37. doi: 10.1093/jnci/djq101. Epub 2010 Apr 28. Erratum in: J Natl Cancer Inst. 2010 Jul 7;102(13):993.

16.

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL.

Hum Pathol. 1992 Sep;23(9):974-9.

PMID:
1355464
17.

Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.

Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P.

Hum Pathol. 2008 Mar;39(3):386-92. doi: 10.1016/j.humpath.2007.07.007. Epub 2008 Jan 9.

PMID:
18187183
18.

Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors.

Roger P, Daures JP, Maudelonde T, Pignodel C, Gleizes M, Chapelle J, Marty-Double C, Baldet P, Mares P, Laffargue F, Rochefort H.

Hum Pathol. 2000 May;31(5):593-600.

PMID:
10836299
19.

Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.

Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ.

J Pathol. 2001 Jul;194(3):327-33.

PMID:
11439365

Supplemental Content

Support Center